COVINA, Calif., May 30, 2023 /PRNewswire/ According to Prophecy Market Insights "Intraocular Lens Market Flourishes with 7.2% CAGR, Envisaged to Cross US$ 7.9 billion Mark by 2032." What
/PRNewswire/ According to Prophecy Market Insights "Intraocular Lens Market Flourishes with 7.2% CAGR, Envisaged to Cross US$ 7.9 billion Mark by 2032.".
May 7, 2021 11:14am The Tecnis Synergy lenses were first launched in Europe and Asia Pacific in 2019, and are currently available in Latin America. J&J said it plans to make the full Tecnis Synergy line available across North America starting this summer. (Pixabay)
Johnson & Johnson continued a string of recent approvals aimed at patients with cataracts, with the latest bringing its newer-generation intraocular lenses to U.S. and Canadian shores.
The company won FDA approval for its vision-correcting Tecnis Synergy and Tecnis Synergy Toric II lenses, with the latter also being cleared by Health Canada. The implanted lenses are designed to replace clouded or impaired lenses while also treating farsightedness, allowing clarity across a range of distances and lighting conditions.